<DOC>
	<DOCNO>NCT01276405</DOCNO>
	<brief_summary>This observational study evaluate Xeloda ( capecitabine ) monotherapy effect disease-free survival patient colon cancer stage III ( Duke C ) surgical resection . Data collect 3 year .</brief_summary>
	<brief_title>An Observational Study Xeloda ( Capecitabine ) Monotherapy Patients With Colorectal Cancer ( AXEL )</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<criteria>Adult patient , age 18 year Presence colon adenocarcinoma Surgical resection colon cancer stage III ( Duke C ) Prior adjuvant therapy Xeloda monotherapy Contraindications Xeloda</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>